SA PRO
Free Account
Cullinan Therapeutics, Inc.CGEMNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
8 analysts·Limited coverage
100%
Rating Distribution
Strong Buy
00%
Buy
8100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 143% higher.

Bear Case
$26.00
+105%
Consensus
$30.83
+143%
Bull Case
$38.00
+199%
Price Range8 analysts
Low
Consensus
High
$26.00
$38.00
Current Target
Current Price
$12.71
Upside to Target
$18.12

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Feb 2, 2026Guggenheim
Cullinan Therapeutics initiated with a Buy at Guggenheim
Target:$30.00
+150.8%from $11.96
Jan 8, 2026H.C. Wainwright
Cullinan Therapeutics price target raised to $27 from $26 at H.C. Wainwright
Target:$27.00
+150.7%from $10.77
Jan 8, 2026Morgan Stanley
Cullinan Therapeutics price target raised to $30 from $28 at Morgan Stanley
Target:$30.00
+174.2%from $10.94
Dec 9, 2025Wedbush
Cullinan Therapeutics price target raised to $34 from $25 at Wedbush
Target:$34.00
+179.1%from $12.18
Nov 24, 2025BTIG
Cullinan Therapeutics price target raised to $38 from $32 at BTIG
Target:$38.00
+219.3%from $11.90
Nov 20, 2025New Street
Cullinan Therapeutics price target raised to $26 from $24 at H.C. Wainwright
Target:$26.00
+191.4%from $8.92
Oct 24, 2024UBS
UBS Starts Cullinan Oncology Inc. (CGEM) at Buy
Target:$30.00
+92.2%from $15.61
Aug 8, 2024Morgan Stanley
Cullinan Oncology Inc. (CGEM) PT Lowered to $38 at Morgan Stanley
Target:$38.00
+132.0%from $16.38
May 16, 2024H.C. Wainwright
Cullinan Therapeutics price target lowered to $28 from $29 at H.C. Wainwright
Target:$28.00
+4.8%from $26.72
Apr 17, 2024BTIG
Cullinan Oncology Inc. (CGEM) PT Raised to $30 at BTIG
Target:$30.00
+73.2%from $17.32
Apr 16, 2024H.C. Wainwright
Cullinan Oncology price target lowered to $29 from $34 at H.C. Wainwright
Target:$29.00
+64.5%from $17.63
Feb 3, 2023Morgan Stanley
Morgan Stanley Maintains Overweight on Cullinan Oncology, Lowers Price Target to $19
Target:$19.00
+59.5%from $11.91

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance